EPISODE · Nov 3, 2020 · 9 MIN
Updates in non-small cell lung cancer from ESMO
from VJOncology Podcast · host VJOncology
Significant advances have been made in the treatment of non-small cell lung cancer (NSCLC), the most common form of lung cancer. The latest trial updates in oncogene-targeted therapy for patients with advanced ALK-positive NSCLC were presented during the European Society for Medical Oncology (ESMO) 2020 Virtual Congress.
Embed this episode
NOW PLAYING
Updates in non-small cell lung cancer from ESMO
0:00
9:57
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of VJOncology Podcast?
This episode is 9 minutes long.
When was this VJOncology Podcast episode published?
This episode was published on November 3, 2020.
Can I download this VJOncology Podcast episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!